ranolazine krka 500 mg prolonged release tablets
krka, d.d., novo mesto - ranolazine - prolonged-release tablet - ranolazine
ranolazine krka 750 mg prolonged release tablets
krka, d.d., novo mesto - ranolazine - prolonged-release tablet - ranolazine
isoptin sr 240 mg prolonged-release tablets
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - prolonged-release tablet - verapamil hydrochloride 240 mg - calcium channel blockers
brufen retard 800mg prolonged release tablets
viatris healthcare limited - ibuprofen - prolonged-release tablet - propionic acid derivatives; ibuprofen
janumet xr 100/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle
merck sharp & dohme (australia) pty ltd - metformin hydrochloride, quantity: 1000 mg; sitagliptin phosphate monohydrate, quantity: 128.5 mg (equivalent: sitagliptin, qty 100 mg) - tablet, modified release - excipient ingredients: povidone; hypromellose; colloidal anhydrous silica; sodium stearylfumarate; propyl gallate; macrogol 3350; kaolin; carnauba wax; titanium dioxide; hyprolose; indigo carmine aluminium lake - janumet xr (sitagliptin phosphate monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.,[see sections 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration].
janumet xr 50/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle
merck sharp & dohme (australia) pty ltd - metformin hydrochloride, quantity: 1000 mg; sitagliptin phosphate monohydrate, quantity: 64.25 mg (equivalent: sitagliptin, qty 50 mg) - tablet, modified release - excipient ingredients: povidone; hypromellose; colloidal anhydrous silica; sodium stearylfumarate; propyl gallate; macrogol 3350; kaolin; carnauba wax; titanium dioxide; hyprolose; iron oxide yellow; indigo carmine aluminium lake - janumet xr (sitagliptin phosphate monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.,[see sections 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration].
metabet sr 1000mg tablets
morningside healthcare ltd - metformin hydrochloride - modified-release tablet - 1gram
bolamyn sr 1000mg tablets
teva uk ltd - metformin hydrochloride - modified-release tablet - 1gram
glucophage xr 1000 mg prolonged-release tablet
merck (pty) ltd 1 friesland drive,longmeadow bussiness - metformin hydrochloride - prolonged-release tablet - 1000 mg metformin hydrochloride per tablet - metformin
voltaren retard 75 mg prolonged release tablets
nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - prolonged-release tablet - diclofenac sodium 75 mg - antiinflammatory and antirheumatic products